Market Overview

ICU Medical Shares Down 30.4% Following Mixed Q2 Results, Cut FY19 Guidance: Adj. EPS From $9-$9.90 To $7.55-$8.15; Hearing KeyBanc Out Saying Buy The Dip


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for ICUI

Aug 2019DowngradesStrong BuyOutperform
Mar 2019MaintainsStrong BuyStrong Buy
Oct 2017Initiates Coverage OnSector Weight

View More Analyst Ratings for ICUI
View the Latest Analyst Ratings

Posted-In: Analyst Color Earnings News Guidance Rumors Analyst Ratings Movers Trading Ideas


Related Articles (ICUI)

The First Half Of 2019 On OTC Markets: By The Numbers

'A Framework': UK Issues Cryptocurrency Guidance